TEVETEN Side Effects

6501860-0 | Asthenia, Hand Deformity, Joint Swelling, Pain, Pain In Extremity, Presyncope
on Dec 10, 2009 Female patient from GERMANY , 75 years of age, was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, hand deformity, joint swelling, pain (What is pain?), pain in extremity, presyncope. Teveten dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), THYROID HORMONES (View Thyroid Hormones Review and Thyroid Hormones Label ). Patient was hospitalized.

6212072-2 | Cachexia, Hip Fracture
Patient was taking Teveten (View Usage). Patient had the following side effects: cachexia, hip fracture on May 28, 2009 from GERMANY Additional patient health information: Female patient , 83 years of age, was diagnosed with cardiac failure, osteoporosis (What is osteoporosis?) and. Teveten dosage: . During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

6201790-8 | Hip Fracture
Adverse event was reported on May 20, 2009 by a Female patient taking Teveten (View Usage) (Dosage: ) . Location: GERMANY , 83 years of age, After Teveten was administered, patient had the following side effects: hip fracture. Patient was hospitalized.

6163537-3 | Hip Fracture
on Apr 16, 2009 Female patient from GERMANY , 83 years of age, was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: hip fracture. Teveten dosage: . Patient was hospitalized.


5991516-5 | Diarrhoea, Lip Oedema, Oral Pain
on Dec 04, 2008 Female patient from GERMANY , 79 years of age, was treated with Teveten (View Usage). Patient had the following side effects: diarrhoea, lip oedema, oral pain. Teveten dosage: 1 Dosage Form Daily. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), BENZYDAMINE HYDROCHLORIDE (View Benzydamine Hydrochloride Review and Benzydamine Hydrochloride Label ), SOLPADEINE PLUS (View Solpadeine Plus Review and Solpadeine Plus Label ), BISOPROLOL FUMARATE (2.5 Mg Daily) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), NAPROXEN SODIUM (250 Mg Daily) (View Naproxen Sodium Review and Naproxen Sodium Label ), FUROSEMIDE (20 Mg Daily) (View Furosemide Review and Furosemide Label ).

5953133-2 | Angioedema, Dysphagia, Dysphonia, Palatal Oedema
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: angioedema, dysphagia, dysphonia, palatal oedema on Nov 06, 2008 from GERMANY Additional patient health information: Male patient , 57 years of age, was diagnosed with hypertension and. Teveten dosage: .

5921279-0 | Diarrhoea, Eye Swelling, Lip Oedema, Oral Pain
Adverse event was reported on Oct 09, 2008 by a Female patient taking Teveten (View Usage) (Dosage: 1 Dosage Form Daily) . Location: GERMANY , 79 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, eye swelling, lip oedema, oral pain. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), BENZYDAMINE HYDROCHLORIDE (View Benzydamine Hydrochloride Review and Benzydamine Hydrochloride Label ), SOLPADEINE PLUS (View Solpadeine Plus Review and Solpadeine Plus Label ), BISOPROLOL FUMARATE (2.5 Mg Daily) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), NAPROXEN SODIUM (250 Mg Daily) (View Naproxen Sodium Review and Naproxen Sodium Label ), FUROSEMIDE (20 Mg Daily) (View Furosemide Review and Furosemide Label ).

5909267-1 | Cough, Feeling Abnormal, Palpitations, Swelling
on Oct 02, 2008 Female patient from GERMANY , 65 years of age, was treated with Teveten (View Usage). Patient had the following side effects: cough, feeling abnormal, palpitations, swelling. Teveten dosage: .

5903973-0 | Diarrhoea, Eye Swelling, Lip Oedema, Oral Pain
on Sep 22, 2008 Female patient from GERMANY , 79 years of age, was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: diarrhoea, eye swelling, lip oedema, oral pain. Teveten dosage: 1 Dosage Form Daily. During the same period patient was treated with LACTULOSE (View Lactulose Review and Lactulose Label ), BENZYDAMINE HYDROCHLORIDE (View Benzydamine Hydrochloride Review and Benzydamine Hydrochloride Label ), SOLPADEINE PLUS (View Solpadeine Plus Review and Solpadeine Plus Label ), BISOPROLOL FUMARATE (2.5 Mg Daily) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), NAPROXEN SODIUM (250 Mg Daily) (View Naproxen Sodium Review and Naproxen Sodium Label ), FUROSEMIDE (20 Mg Daily) (View Furosemide Review and Furosemide Label ).

5866021-7 | Colon Cancer, Dyspnoea, Intestinal Fistula, Melaena, Sepsis
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer, dyspnoea, intestinal fistula, melaena, sepsis (What is sepsis?) on Aug 21, 2008 from GERMANY Additional patient health information: Female patient , 77 years of age, was diagnosed with hypertension, hypercholesterolaemia, depression (What is depression?), insomnia and. Teveten dosage: . During the same period patient was treated with VASEXTEN (View Vasexten Review and Vasexten Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE HYDROCHLORIDE (View Clonidine Hydrochloride Review and Clonidine Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5839802-3 | Blood Pressure Increased, Coronary Artery Occlusion
Adverse event was reported on Dec 22, 2006 by a Female patient taking Teveten (View Usage) (Dosage: ) was diagnosed with hypertension, cardiac failure congestive, cardiovascular event prophylaxis, convulsion, depression (What is depression?) and. Location: UNITED STATES , weighting 150.1 lb, Patient had the following side effects: blood pressure increased, coronary artery occlusion. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ). Patient was hospitalized.

5732151-3 | Cough, Dysphonia, Pharyngeal Oedema
on May 01, 2008 Female patient from GERMANY , 63 years of age, was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: cough, dysphonia, pharyngeal oedema. Teveten dosage: N. Patient was hospitalized.

5689323-6 | Asthma, Bronchitis Chronic, Chronic Obstructive Pulmonary Disease, Chronic Sinusitis
on Mar 21, 2008 Male patient from GERMANY , 61 years of age, was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bronchitis chronic, chronic obstructive pulmonary disease, chronic sinusitis. Teveten dosage: . Patient was hospitalized.

5672130-8 | Chronic Obstructive Pulmonary Disease, Chronic Sinusitis
Patient was taking Teveten (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, chronic sinusitis on Mar 11, 2008 from GERMANY Additional patient health information: Male patient , 61 years of age, . Teveten dosage: . Patient was hospitalized.

5601545-9 | Cerebrovascular Accident, Dyspnoea, Hypertension
Adverse event was reported on Jan 15, 2008 by a Male patient taking Teveten (View Usage) (Dosage: ) . Location: GERMANY , 55 years of age, After Teveten was administered, patient had the following side effects: cerebrovascular accident, dyspnoea, hypertension.

5478601-1 | Pulmonary Oedema
on Sep 27, 2007 Female patient from GERMANY , 77 years of age, was diagnosed with blood pressure increased, hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema. Teveten dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5401983-3 | Chronic Sinusitis, Respiratory Tract Infection
on Jul 10, 2007 Male patient from GERMANY , 61 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: chronic sinusitis, respiratory tract infection. Teveten dosage: . During the same period patient was treated with TEVETEN HCT (View Teveten Hct Review and Teveten Hct Label ), CARMEN (LERCANDIPINE HYDROCHLORIDE) (View Carmen (lercandipine Hydrochloride) Review and Carmen (lercandipine Hydrochloride) Label ).

5391735-5 | Oedema Peripheral, Renal Failure Acute, Syncope
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: oedema peripheral, renal failure acute, syncope on Jul 03, 2007 from BELGIUM Additional patient health information: Male patient , 82 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5391725-2 | Foot Amputation
Adverse event was reported on Jul 03, 2007 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: UNITED STATES , 77 years of age, Patient experienced the following unwanted or unexpected effects: foot amputation. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5372092-7 | Intraocular Pressure Increased
on Jun 11, 2007 Female patient from GREECE , 55 years of age, was diagnosed with essential hypertension and was treated with Teveten (View Usage). Patient had the following side effects: intraocular pressure increased. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ZYLAPOUR (ALLOPURINOL) (View Zylapour (allopurinol) Review and Zylapour (allopurinol) Label ).

5369327-3 | Weight Increased
on Jun 05, 2007 Female patient from GREECE , 69 years of age, was diagnosed with essential hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: weight increased. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

5352217-X | Intraocular Pressure Test Abnormal
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure test abnormal on May 23, 2007 from GREECE Additional patient health information: Female patient , 55 years of age, was diagnosed with essential hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ZYLAPOUR (ALLOPURINOL) (View Zylapour (allopurinol) Review and Zylapour (allopurinol) Label ).

5352216-8 | Intraocular Pressure Test Abnormal
Adverse event was reported on May 23, 2007 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with essential hypertension and. Location: GREECE , 62 years of age, Patient had the following side effects: intraocular pressure test abnormal. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), SALOSPIR (ASPIRIN) (View Salospir (aspirin) Review and Salospir (aspirin) Label ).

5346186-6 | Intraocular Pressure Increased
on May 16, 2007 Female patient from GREECE , 55 years of age, was diagnosed with essential hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: intraocular pressure increased. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5336395-4 | Weight Increased
on May 09, 2007 Female patient from GREECE , 69 years of age, was diagnosed with essential hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: weight increased. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

5332862-8 | Intraocular Pressure Test Abnormal
Patient was taking Teveten (View Usage). Patient had the following side effects: intraocular pressure test abnormal on May 07, 2007 from GREECE Additional patient health information: Female patient , 55 years of age, was diagnosed with essential hypertension and. Teveten dosage: 6000 Mg Qd Po. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5332860-4 | Caudal Regression Syndrome, Foetal Disorder, Hypoperfusion, Pulmonary Hypoplasia, Stillbirth
Adverse event was reported on Apr 25, 2007 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Daily Po) . Location: UNITED KINGDOM , weighting 235.9 lb, After Teveten was administered, patient had the following side effects: caudal regression syndrome, foetal disorder, hypoperfusion, pulmonary hypoplasia, stillbirth. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ).

5332830-6 | Intraocular Pressure Test Abnormal
on May 07, 2007 Male patient from GREECE , 62 years of age, was diagnosed with essential hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure test abnormal. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

5286974-8 | Syncope
on Mar 14, 2007 Female patient from GERMANY , 84 years of age, weighting 121.3 lb, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: syncope. Teveten dosage: 600 Mg Qhs; Po. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), NIFURTOINOL (View Nifurtoinol Review and Nifurtoinol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FLUTICASONE PROPIONATE SALMETEROL (View Fluticasone Propionate Salmeterol Review and Fluticasone Propionate Salmeterol Label ). Patient was hospitalized.

5286973-6 | Grand Mal Convulsion
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: grand mal convulsion on Mar 14, 2007 from GERMANY Additional patient health information: Female patient , 61 years of age, was diagnosed with hypertension, muscle spasms, fibromyalgia, insomnia and. Teveten dosage: 600 Mg Qhs; Po. During the same period patient was treated with SULFATE QUININE (250 Mg Unk; Po) (View Sulfate Quinine Review and Sulfate Quinine Label ), AMITRIPTYLINE CHLORHYDRATE (25 Mg Qd; Po) (View Amitriptyline Chlorhydrate Review and Amitriptyline Chlorhydrate Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), METFORMIN (View Metformin Review and Metformin Label ), GLIQUIDONE (View Gliquidone Review and Gliquidone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

5252878-X | Crohn's Disease, Diverticulum, White Blood Cell Count Increased
Adverse event was reported on Feb 12, 2007 by a Male patient taking Teveten (View Usage) (Dosage: 300 Mg Qd Po) was diagnosed with hypertension and. Location: UNITED KINGDOM , 79 years of age, Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?), diverticulum, white blood cell count increased.

5248574-5 | Faecal Incontinence
on Feb 07, 2007 Male patient from AUSTRALIA , 57 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: faecal incontinence. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ).

5248569-1 | Angioedema, Aortic Aneurysm, Vasculitis, Vocal Cord Paralysis
on Feb 06, 2007 Male patient from GERMANY , 73 years of age, was diagnosed with hypertonia and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: angioedema, aortic aneurysm (What is aortic aneurysm?), vasculitis (What is vasculitis?), vocal cord paralysis. Teveten dosage: . Patient was hospitalized.

5236715-5 | Iritis
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: iritis on Jan 25, 2007 from AUSTRALIA Additional patient health information: Female patient , 64 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd; Po.

5229666-3 | Hypertension
Adverse event was reported on Nov 12, 2004 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) . Location: AUSTRALIA , 81 years of age, Patient had the following side effects: hypertension.

5229664-X | Faecal Incontinence
on Oct 30, 2004 Male patient from AUSTRALIA , 57 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: faecal incontinence. Teveten dosage: 600 Mg Qd Po.

5226206-X | Iritis
on Jan 12, 2007 Female patient from AUSTRALIA , 64 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: iritis. Teveten dosage: 600 Mg Qd Po.

5196225-0 | Angioneurotic Oedema, Aortic Aneurysm, Vasculitis, Vocal Cord Paralysis
Patient was taking Teveten (View Usage). Patient had the following side effects: angioneurotic oedema, aortic aneurysm (What is aortic aneurysm?), vasculitis (What is vasculitis?), vocal cord paralysis on Dec 05, 2006 from GERMANY Additional patient health information: Male patient , 73 years of age, was diagnosed with hypertonia and. Teveten dosage: . Patient was hospitalized.

5178590-3 | Angioneurotic Oedema, Disease Recurrence, Vasculitis, Vocal Cord Paralysis
Adverse event was reported on Nov 23, 2006 by a Male patient taking Teveten (View Usage) (Dosage: ) was diagnosed with hypertonia and. Location: GERMANY , 73 years of age, After Teveten was administered, patient had the following side effects: angioneurotic oedema, disease recurrence, vasculitis (What is vasculitis?), vocal cord paralysis. Patient was hospitalized.

5165197-7 | Erectile Dysfunction
on Nov 10, 2006 Male patient from UNITED KINGDOM , 51 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: erectile dysfunction (What is erectile dysfunction?). Teveten dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ATOVASTATIN (View Atovastatin Review and Atovastatin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ).

5156681-0 | Acute Coronary Syndrome, Acute Myocardial Infarction, Arrhythmia, Treatment Noncompliance
on Oct 31, 2006 Male patient from CANADA , 55 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, arrhythmia (What is arrhythmia?), treatment noncompliance. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

5150341-8 | Acute Coronary Syndrome, Acute Myocardial Infarction, Angina Pectoris, Arrhythmia, Treatment Noncompliance
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: acute coronary syndrome, acute myocardial infarction, angina pectoris, arrhythmia (What is arrhythmia?), treatment noncompliance on Oct 23, 2006 from CANADA Additional patient health information: Male patient , 55 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

5141846-4 | Acute Coronary Syndrome, Acute Myocardial Infarction, Angina Pectoris, Arrhythmia, Treatment Noncompliance
Adverse event was reported on Oct 16, 2006 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: CANADA , 55 years of age, Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, acute myocardial infarction, angina pectoris, arrhythmia (What is arrhythmia?), treatment noncompliance. Patient was hospitalized.

5141824-5 | Depressed Level Of Consciousness, Somnolence
on Oct 12, 2006 Female patient from FINLAND , 56 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: depressed level of consciousness, somnolence. Teveten dosage: 6000 Mg Qd Po.

5127880-9 | Pulmonary Oedema
on Sep 25, 2006 Female patient from CANADA , 76 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: pulmonary oedema. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIABETA (View Diabeta Review and Diabeta Label ), RESTORIL (View Restoril Review and Restoril Label ), LUVOX SA (View Luvox Sa Review and Luvox Sa Label ), LIPIDIL (View Lipidil Review and Lipidil Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

5029431-6 | Animal Bite, Animal Scratch, Blood Creatine Phosphokinase Increased, Blood Potassium Decreased, Cellulitis, Coronary Artery Disease, Diabetes Mellitus, Dyspepsia, Hypercholesterolaemia
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: animal bite (What is animal bite?), animal scratch, blood creatine phosphokinase increased, blood potassium decreased, cellulitis (What is cellulitis?), coronary artery disease (What is coronary artery disease?), diabetes mellitus, dyspepsia, hypercholesterolaemia on May 29, 2006 from SOUTH AFRICA Additional patient health information: Male patient , 68 years of age, . Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FEMOSTATIN (View Femostatin Review and Femostatin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

4977108-5 | Blood Pressure Decreased, Diplopia, Myalgia, Vertigo
Adverse event was reported on Jul 11, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Qam Po) was diagnosed with hypertension and. Location: UNITED STATES , 70 years of age, weighting 112.0 lb, Patient had the following side effects: blood pressure decreased, diplopia, myalgia, vertigo.

4977105-X | Fall, Intervertebral Disc Protrusion, Rhabdomyolysis
on Jul 12, 2005 Female patient from UNITED STATES , 65 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: fall (What is fall?), intervertebral disc protrusion, rhabdomyolysis. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with INDERAL (View Inderal Review and Inderal Label ), DONNATAL (View Donnatal Review and Donnatal Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), CLARINEX (View Clarinex Review and Clarinex Label ), NEXIUM (View Nexium Review and Nexium Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MULTIVTIAMIN (View Multivtiamin Review and Multivtiamin Label ).

4941554-6 | Cerebrovascular Accident, Loss Of Consciousness
on Feb 22, 2006 Male patient from AUSTRALIA , 54 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, loss of consciousness. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), PERIDOPRIL AND INDAPAMIDE (View Peridopril And Indapamide Review and Peridopril And Indapamide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

4924488-2 | C-reactive Protein Increased, Hypotension, Oesophagitis, Syncope
Patient was taking Teveten (View Usage). Patient had the following side effects: c-reactive protein increased, hypotension, oesophagitis, syncope on Feb 06, 2006 from GERMANY Additional patient health information: Male patient , 75 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with HYTRIN (10 Mg Qd Po) (View Hytrin Review and Hytrin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), GINKO EXTRACT (View Ginko Extract Review and Ginko Extract Label ). Patient was hospitalized.